High levels of serum basic fibroblast growth factor in children with biliary atresia

Hepato-Gastroenterology

Volumn 55, Issue 85, 2008, Pages 1184-1188

  Honsawek, Sittisak ^a   Chongsrisawat, Voranush ^a   Vejchapipat, Paisarn ^a   Thawornsuk, Nutchanart ^a   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Basic fibroblast growth factor; Biliary atresia; Jaundice; Portal hypertension

Indexed keywords

BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR 2;

ARTICLE; BILE DUCT ATRESIA; BLOOD; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; FEMALE; HUMAN; MALE; PORTOENTEROSTOMY; RISK FACTOR; ROUX Y ANASTOMOSIS; TREATMENT OUTCOME;

ANASTOMOSIS, ROUX-EN-Y; BILIARY ATRESIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; PORTOENTEROSTOMY, HEPATIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 58149378223     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Balistreri WF, Grand R, Hoofnagle JH, et al.: Biliary atresia: current concepts and research directions. Hepatology 1996; 23:1682-1692.
2. Karrer FM, Price MR, Bensard DD, et al.: Long-term results with the Kasai operation for biliary atresia. Arch Surg 1996; 131:493-496. (Pubitemid 26136370)
3. A-Kader HH, Abdel-Hameed A, Al-Shabrawi M, et al.: Is biliary atresia an autoimmune disease? Eur J Gastroenterol Hepatol 2003; 15:447.
4. Gabele E, Brenner DA, Rippe RA: A Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci 2003; 8:D69-D77. (Pubitemid 39069964)
5. Schmeling DJ, Oldham KT, Guice KS, Kunkel RG, Johnson KJ: Experimental obliterative cholangitis. A model for the study of biliary atresia. Ann Surg 1991; 213:350-355.
6. Knecht A, Fine LG, Kleinman KS, et al.: Fibroblasts of rabbit kidney in culture II. Paracrine stimulation of papillary fibroblasts by PDGF. Am J Physiol 1991; 261:F292-F299.
7. Friesel RE, Maciag T: Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 1995; 9:919-925.
8. Bikfalvi A, Klein S, Pintucci G, Rifkin DB: Biological roles of fibroblast growth factor-2. Endocr Rev 1997; 18:26-45. (Pubitemid 27076454)
9. Hioki O, Minemura M, Shimizu Y: Expression and localization of basic fibroblast growth factor (bFGF) in the repair process of rat liver injury. J Hepatol 1996; 24:217-224. (Pubitemid 26057957)
10. Hsu PI, Chow NH, Lai KH, et al.: Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma. Anticancer Res 1997; 17:2803-2809.
11. Honsawek S, Chongsrisawat V, Vejchapipat P, et al.: Serum interleukin-8 in children with biliary atresia: relationship with disease stage and biochemical parameters. Pediatr Surg Int 2005; 21:73-77. (Pubitemid 40248254)
12. Urushihara N, Iwagaki H, Yagi T, et al.: Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia. J Pediatr Surg 2000; 35:446-449. (Pubitemid 30131608)
13. Rosensweig JN, Omori M, Page K, et al.: Transforming growth factor- beta1 in plasma and liver of children with liver disease. Pediatr Res 1998; 44:402-409. (Pubitemid 28389999)
14. Yoshida S, Nio M, Hayashi Y, et al.: Serum insulin-like growth factor-I in biliary atresia. J Pediatr Surg 2003; 38:211-215. (Pubitemid 36160066)
15. Vejchapipat P, Theamboonlers A, Chaokhonchai R, et al.: Serum hepatocyte growth factor and clinical outcome in biliary atresia. J Pediatr Surg 2004; 39:1045-1049. (Pubitemid 38881161)
16. Chongsrisawat V, Chatchatee P, Samranamruajkit R, et al.: Plasma endothelin-1 levels in patients with biliary atresia: possible role in development of portal hypertension. Pediatr Surg Int 2003; 19:478-481. (Pubitemid 37092747)
17. Tamatani T, Kobayashi H, Tezuka K, et al.: Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia. Biochem Biophys Res Commun 1998; 251:748-752. (Pubitemid 28512782)
18. Kadono T, Kikuchi K, Kubo M, Fujimoto M, Tamaki K: J Am Acad Dermatol 1996; 35:392-397.
19. Hsu PI, Chow NH, Lai KH et al.: Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma. Anticancer Res 1997; 17:2803-2809.
20. Jin-no K, Tanimizu M, Hyodo I, Kurimoto F, Yamashita T: Plasma level of basic fibroblast growth factor increases with progression of chronic liver disease. J Gastroenterol 1997; 32:119-121. (Pubitemid 27075893)
21. Rosmorduc O, Wendum D, Corpechot C, et al.: Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol 1999; 155:1065-1073. (Pubitemid 29488914)
22. Friedman SL: The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328:1828-1835.
23. Rosenbaum J, Blazejewski S, Preaux AM, et al.: Fibroblast growth factor 2 and transforming growth factor beta 1 interactions in human liver myofibroblasts. Gastroenterology 1995; 109:1986-1996.
24. Jin-no K, Tanimizu M, Hyodo I, Kurimoto F, Yamashita T: Plasma level of basic fibroblast growth factor increases with progression of chronic liver disease. J Gastroenterol 1997; 32:119-121. (Pubitemid 27075893)
25. Baird A, Esch F, Mormede P, et al.: Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues. Recent Prog Horm Res 1986; 42:143-205.
26. Nagasaki T, Lieberman MA: Liver contains heparin-binding growth factors as the major growth factor for cultured fibroblasts. Hepatology 1991; 13:6-14.
27. Bishop GA, Matsumoto Y, McCaughan GW, Kenney JS: Identification of cytokine protein expression in human liver allograft rejection: methods development and expression of IL-1 beta, IL-6, IFN-gamma, and basic fibroblast growth factor. Transplant Proc 1992; 24:2310-2312.
28. Charlotte F, Win KM, Preaux AM, et al.: Immunolocalization of heparin-binding growth factors (HBGF) types 1 and 2 in rat liver. Selective hyperexpression of HBGF-2 in carbon tetrachloride-induced fibrosis. J Pathol 1993; 169:471-476. (Pubitemid 23128470)
29. Burgess WH, Maciag T: The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989; 58:575-606. (Pubitemid 19172981)
30. Presta M, Statuto M, Rusnati M, Dell'Era P, Ragnotti G: Characterization of a Mr 25,000 basic fibroblast growth factor form in adult, regenerating, and fetal rat liver. Biochem Biophys Res Commun 1989; 164:1182-1189. (Pubitemid 19283969)
31. Baruch Y, Shoshany G, Neufeld G, Enat R: Basic fibroblast growth factor is hepatotropic for rat liver in regeneration. J Hepatol 1995; 23:328-332.